tiprankstipranks
Trending News
More News >
Oncology Pharma (ONPH)
OTHER OTC:ONPH
US Market

Oncology Pharma (ONPH) Income Statement

Compare
169 Followers

Oncology Pharma Income Statement

Last quarter (Q3 2022), Oncology Pharma's total revenue was $0.00, a decrease of ― from previous quarter. In Q3, Oncology Pharma's net income was $-254.88K. See Oncology Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -779.00$ -1.11K$ -1.11K
Operating Expenses
$ 62.05K$ 14.41M$ 402.77K$ 817.75K
Depreciation and Amortization
$ 236.56K$ 779.00$ 1.11K$ 1.11K
EBITDA
$ 228.68K$ -14.66M$ -181.45K$ -817.75K
Operating Income
$ -62.05K$ -14.41M$ -403.88K$ -818.86K
Other Income/Expenses
$ -104.56M$ -83.06M$ 196.33K$ -31.53K
Pretax Income
$ -104.63M$ -97.47M$ -207.56K$ -850.40K
Net Income
$ -104.63M$ -97.47M$ -207.56K$ -850.40K
Per Share Metrics
Basic EPS
$ -3.42$ -6.76$ -0.12$ -0.72
Diluted EPS
$ -3.42$ -6.76$ -0.12$ -0.72
Weighted Average Shares Outstanding
30.55M 14.42M 1.68M 1.19M
Weighted Average Shares Outstanding (Diluted)
30.55M 14.42M 1.68M 1.19M
Currency in USD

Oncology Pharma Earnings and Revenue History